openPR Logo
Press release

Neuroleptic Market Share, Trends, Future Outlook, Analysis and Forecast 2023-2030

08-08-2023 03:31 PM CET | Health & Medicine

Press release from: Orion Market Research

Neuroleptic Market Share, Trends, Future Outlook, Analysis

The Global Neuroleptic market is estimated to grow at a significant CAGR during the forecast period. Antipsychotic drugs, often known as major sedatives or neuroleptics, are used to treat psychosis. Schizophrenia, hallucinations, delusions, bipolar disorder, and other psychotic conditions are among the most prevalent for which these drugs are prescribed. Because of the growing number of Schizophrenic patients, the market for antipsychotic drugs is expected to grow. According to the American Psychiatric Association (APA), around one out of every twenty-four patients in 2018 had severe mental illnesses, including major psychotic disorders.

A full report of Neuroleptic Market is available at: https://www.omrglobal.com/industry-reports/neuroleptic-market

The rising incidence of psychiatric disorders places a significant pressure on healthcare system. As a result, the government is focused on raising awareness about disorders and the efficacy of drugs used to treat them. As a result, there is a huge demand for highly effective and safe drugs to treat people with psychotic disorders all over the globe. Furthermore, the firms are concentrating on the identification of innovative antipsychotic injectable drugs that reduce the need to monitor the patient's drug consumption. Schizophrenia and psychotic disorders have a high incidence, which is driving the global antipsychotic drug market. Additional reasons driving the market growth for antipsychotic drugs include increased drug abuse, over-prescription of drugs, and addiction to antipsychotic drugs.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/neuroleptic-market

In March 2020, Dr. Reddy's Laboratories announced the launch of Ziprasidone Mesylate for injection, 20 mg (base)/ml single-dose vials, in the United States. Ziprasidone Mesylate for injection is the generic therapeutic equivalent to Pfizer's Geodon injection.

In January 2020, The US Food and Medication Administration (FDA) had approved Alkermes' experimental antipsychotic drug candidate ALKS 3831 (olanzapine/samidorphan), which is used to treat schizophrenia and bipolar I disorder.

Market Coverage

The market number available for - 2020-2027
Base year- 2020
Forecast period- 2021-2027
Segment covered
o By Type

o By Application

o By distribution

Competitive Landscape- Eli Lily and Company., AstraZeneca., GlaxoSmithKline plc., Johnson & Johnson., Otsuka Pharmaceutical Co, Ltd., and Pfizer Inc., among others.

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominates the market in base year?
Which segment and region will project fastest growth in the market?
How COVID-19 impacted the market?
o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Market Segmentation

By Type

Risperidone
Olanzapine
Quetiapine
Ziprasidone
Aripiprazole
Paliperidone
Lurasidone

By Application

Bipolar I Disorder
Schizophrenia
Schizoaffective Disorder
Major Depressive Disorder (MDD)

By Distribution

Hospital Pharmacy
Retail Pharmacy
Drug Store
E-commerce

Neuroleptic Market- Segment by Region

North America

United States
Canada

Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Middle East & Africa
Latin America

Company Profiles

Eli Lily and Company.
GlaxoSmithKline plc.
Johnson & Johnson.
Otsuka Pharmaceutical Co, Ltd.
Pfizer Inc.

Reasons to Buying From us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuroleptic Market Share, Trends, Future Outlook, Analysis and Forecast 2023-2030 here

News-ID: 3158711 • Views:

More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033. Infrastructure as Code (IaC) Service Market Overview The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to Understanding the Process
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033. Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,
Property Management Service Market Rising Demand and Growth Forecast Through 2033
Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033. Property Management Service Market Overview The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSilicon Technologies Co., Ltd., ZTE Corporation,
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033. 5G Chipset Market Overview The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT

All 5 Releases


More Releases for Neuroleptic

Neuroleptic Market Increasing Demand, Growth Analysis and Future Outlook by 2030
The Global Neuroleptic market is estimated to grow at a significant CAGR during the forecast period. Antipsychotic drugs, often known as major sedatives or neuroleptics, are used to treat psychosis. Schizophrenia, hallucinations, delusions, bipolar disorder, and other psychotic conditions are among the most prevalent for which these drugs are prescribed. Because of the growing number of Schizophrenic patients, the market for antipsychotic drugs is expected to grow. According to the
Neuroleptic Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)
Neuroleptic Drugs Market Overview: Neuroleptic Drugs Market Witnesses Steady Growth with Anticipated CAGR of 5.6% The global neuroleptic drugs market is poised to witness substantial growth, projecting a Compound Annual Growth Rate (CAGR) of 5.6% throughout the forecast period spanning from 2022 to 2029. Antipsychotics, also recognized as neuroleptics, continue to be at the forefront of psychiatric treatment, notably combating schizophrenia and a spectrum of other psychotic disorders. Market Metrics CAGR: 5.6% Segments Covered: By
Neuroleptic Market Outlook 2029: Presents Market Insights & Depth Analysis
This Neuroleptic Market research report focuses more on a number of distinctive as well as foremost market sectors. It further focuses market segmentation. Industry-specific interviews are carried out with market players to foresee future business growth. Various facets of the industry are also depicted here under each industry sector. Future development visions and a wide range of subjects are covered in this Neuroleptic Market study report. All this crucial data
Neuroleptic Market Share 2023: Global Trends, Key Players, Industry Analysis and …
The Global Neuroleptic market is estimated to grow at a significant CAGR during the forecast period. Antipsychotic drugs, often known as major sedatives or neuroleptics, are used to treat psychosis. Schizophrenia, hallucinations, delusions, bipolar disorder, and other psychotic conditions are among the most prevalent for which these drugs are prescribed. Because of the growing number of Schizophrenic patients, the market for antipsychotic drugs is expected to grow. According to the
Neuroleptic Market Share 2021: Global Trends, Key Players, Industry Analysis and …
The Global Neuroleptic market is estimated to grow at a significant CAGR during the forecast period. Antipsychotic drugs, often known as major sedatives or neuroleptics, are used to treat psychosis. Schizophrenia, hallucinations, delusions, bipolar disorder, and other psychotic conditions are among the most prevalent for which these drugs are prescribed. Because of the growing number of Schizophrenic patients, the market for antipsychotic drugs is expected to grow. According to the
Neuroleptic Market Analysis and Growth to 2025: by Key Companies Johnson & Johns …
The research study offers powerful guidelines for market players to compete well against other participants operating in the global Neuroleptic market. It brings to light crucial market dynamics including drivers, challenges, restraints, trends, and opportunities. Readers are provided with detailed qualitative and quantitative analysis, PESTLE analysis, absolute dollar opportunity analysis, and Porter’s Five Forces analysis that focus on various aspects of the global Neuroleptic Market. The report includes regional growth